Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer

Abstract excerpt

INTRODUCTION: Protein tyrosine kinase inhibitors are currently one of the most important classes of cancer drugs and one of the most impressive approaches of targeted cancer therapy. Aberrant activation of tyrosine kinase pathways is among the most dysregulated molecular pathways in human cancers; therefore, a large number of tyrosine kinases may serve as valuable molecular targets. To date, several inhibitors of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Myeloid Leukemia Treatments
• Share to Fibroblast Growth Factor Research
• Share to HER2/EGFR in Cancer Research